| Literature DB >> 23497320 |
Josep A Calduch-Giner1, Azucena Bermejo-Nogales, Laura Benedito-Palos, Itziar Estensoro, Gabriel Ballester-Lozano, Ariadna Sitjà-Bobadilla, Jaume Pérez-Sánchez.
Abstract
BACKGROUND: The gilthead sea bream (Sparus aurata) is the main fish species cultured in the Mediterranean area and constitutes an interesting model of research. Nevertheless, transcriptomic and genomic data are still scarce for this highly valuable species. A transcriptome database was constructed by de novo assembly of gilthead sea bream sequences derived from public repositories of mRNA and collections of expressed sequence tags together with new high-quality reads from five cDNA 454 normalized libraries of skeletal muscle (1), intestine (1), head kidney (2) and blood (1).Entities:
Mesh:
Substances:
Year: 2013 PMID: 23497320 PMCID: PMC3606596 DOI: 10.1186/1471-2164-14-178
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Statistics for 454 pyrosequencing libraries
| | | | | | |
| High-quality reads | 447,166 | 614,899 | 576,796 | 577,112 | 729,941 |
| Average read length (bp) | 294 | 304 | 290 | 349 | 320 |
| Total Megabases | 131.5 | 186.9 | 167.3 | 201.4 | 233.6 |
| | | | | | |
| Number of contigs | 7,808 | 9,475 | 12,003 | 14,008 | 12,474 |
| Reads assembled | 314,628 | 482,080 | 389,934 | 392,195 | 508,826 |
| Average contig length (bp) | 968 | 1,090 | 831 | 1,059 | 1,148 |
| Number of singletons | 48,750 | 80,527 | 114,984 | 105,431 | 91,885 |
| Average singleton length (nt) | 316 | 298 | 284 | 318 | 334 |
| Total consensus Megabases | 23.0 | 34.3 | 42.7 | 48.4 | 45.0 |
| Average sequences coverage | 6.4 | 6.3 | 4.0 | 4.2 | 5.8 |
Sequence characteristics of the five 454 normalized libraries derived from skeletal muscle, intestine, blood and head kidney (HK-38, early parasite infection; HK 105, chronic parasite infection).
Figure 1Schematic representation of the data processing pipeline for the assembly and annotation of gilthead sea bream transcriptome.
assembly statistics
| Number of contigs | 113,927 |
| Reads assembled | 2,765,597 |
| Average contig length (bp) | 762 |
| Number of singletons | 11,336 |
| Average singleton length (nt) | 378 |
| Total consensus Megabases | 91.1 |
| Average sequences coverage | 22.2 |
Figure 2Characteristics of assembled gilthead sea bream transcriptome. (A) Distribution of number of reads per contig. (B) Size distribution of reads after the global assembly. The number of annotated (white bars) and non-annotated sequences (black bars) are represented for each category.
Figure 3Quality control of the gilthead sea bream transcriptome annotation. Frequency distribution of BlastX hit results for annotated (A) and non-annotated (B) stickleback transcripts.
Figure 4Distribution of multilevel GO annotation terms for biological process and molecular function in the gilthead sea bream transcriptome.
Most significant canonical pathways determined by Ingenuity Pathway Analysis and represented in the assembled gilthead sea bream transcriptome
| Regulation of eIF4 and p70S6K Signaling | 1.58E-23 | 130 | Erythropoietin Signaling | 8.32E-08 | 56 |
| Purine Metabolism | 7.94E-23 | 219 | Ubiquinone Biosynthesis | 9.12E-08 | 58 |
| EIF2 Signaling | 3.98E-21 | 156 | AMPK Signaling | 9.33E-08 | 100 |
| Protein Ubiquitination Pathway | 7.94E-20 | 207 | Induction of Apoptosis by HIV1 | 1.05E-07 | 51 |
| Glucocorticoid Receptor Signaling | 2.51E-17 | 203 | IL-2 Signaling | 1,17E-07 | 46 |
| mTOR Signaling | 2.51E-16 | 148 | CD40 Signaling | 1,20E-07 | 53 |
| Molecular Mechanisms of Cancer | 6.31E-16 | 250 | Role of NFAT in Cardiac Hypertrophy | 1,29E-07 | 131 |
| Mitochondrial Dysfunction | 1.00E-15 | 114 | HGF Signaling | 1,48E-07 | 77 |
| Integrin Signaling | 6.31E-14 | 155 | FLT3 Signaling in Hematopoietics | 1,55E-07 | 59 |
| Inositol Phosphate Metabolism | 2.51E-13 | 122 | Progenitor Cells | | |
| Thrombin Signaling | 1.58E-12 | 147 | Fcγ Receptor-mediated Phagocytosis in | 1,58E-07 | 73 |
| Signaling by Rho Family GTPases | 1.58E-12 | 174 | Macrophages and Monocytes | | |
| Estrogen Receptor Signaling | 3.16E-12 | 104 | Sphingosine-1-phosphate Signaling | 1,66E-07 | 86 |
| CXCR4 Signaling | 5.01E-12 | 121 | FAK Signaling | 1,66E-07 | 69 |
| Oxidative Phosphorylation | 6.31E-12 | 115 | Paxillin Signaling | 2,09E-07 | 78 |
| Acute Phase Response Signaling | 7.94E-12 | 130 | Small Cell Lung Cancer Signaling | 2,40E-07 | 58 |
| Breast Cancer Regulation by Stathmin1 | 1.26E-11 | 147 | T Cell Receptor Signaling | 3,31E-07 | 75 |
| Type II Diabetes Mellitus Signaling | 3.98E-11 | 94 | B Cell Receptor Signaling | 3,31E-07 | 105 |
| Huntington’s Disease Signaling | 5.01E-11 | 161 | Production of Nitric Oxide and Reactive | 3,72E-07 | 126 |
| Pyrimidine Metabolism | 7.94E-11 | 111 | Oxygen Species in Macrophages | | |
| NGF Signaling | 7.94E-11 | 86 | LPS-stimulated MAPK Signaling | 3,89E-07 | 59 |
| PI3K/AKT Signaling | 1.10E-10 | 96 | Insulin Receptor Signaling | 3,98E-07 | 96 |
| RAR Activation | 1.38E-10 | 130 | Cyclins and Cell Cycle Regulation | 3,98E-07 | 63 |
| Androgen Signaling | 1.62E-10 | 91 | PI3K Signaling in B Lymphocytes | 4,57E-07 | 99 |
| Tight Junction Signaling | 1.86E-10 | 120 | IGF-1 Signaling | 4,68E-07 | 76 |
| Chronic Myeloid Leukemia Signaling | 4.68E-10 | 78 | p53 Signaling | 5,25E-07 | 72 |
| NRF2-mediated Oxidative Stress Response | 8.51E-10 | 134 | VEGF Signaling | 5,62E-07 | 68 |
| PPARα/RXRα Activation | 1.12E-09 | 128 | Prostate Cancer Signaling | 6,03E-07 | 64 |
| Actin Cytoskeleton Signaling | 1.78E-09 | 154 | Nicotinate and Nicotinamide Metabolism | 6,46E-07 | 77 |
| Ceramide Signaling | 2.00E-09 | 66 | Relaxin Signaling | 6,46E-07 | 98 |
| Role of Tissue Factor in Cancer | 2.29E-09 | 87 | Glioma Signaling | 7,24E-07 | 73 |
| Hereditary Breast Cancer Signaling | 3.31E-09 | 92 | Pentose Phosphate Pathway | 7,94E-07 | 29 |
| ERK/MAPK Signaling | 3.72E-09 | 135 | Pancreatic Adenocarcinoma Signaling | 8,13E-07 | 80 |
| NF-κB Activation by Viruses | 4.57E-09 | 62 | Mitotic Roles of Polo-Like Kinase | 8,51E-07 | 51 |
| Apoptosis Signaling | 4.68E-09 | 73 | Acute Myeloid Leukemia Signaling | 9,33E-07 | 61 |
| Gα12/13 Signaling | 4.90E-09 | 93 | PDGF Signaling | 9,33E-07 | 57 |
| Cardiac Hypertrophy Signaling | 5.13E-09 | 159 | CNTF Signaling | 1,05E-06 | 44 |
| Rac Signaling | 5.37E-09 | 83 | Endometrial Cancer Signaling | 1,05E-06 | 44 |
| Germ Cell-Sertoli Cell Junction Signaling | 6.17E-09 | 118 | Thrombopoietin Signaling | 1,17E-06 | 46 |
| ILK Signaling | 6.76E-09 | 135 | Melanocyte Development and Pigmentation | 1,29E-06 | 66 |
| Renin-Angiotensin Signaling | 7.94E-09 | 86 | Signaling | | |
| Protein Kinase A Signaling | 8.51E-09 | 212 | Prolactin Signaling | 1,45E-06 | 58 |
| Aldosterone Signaling in Epithelial Cells | 8.91E-09 | 117 | Colorectal Cancer Metastasis Signaling | 1,58E-06 | 161 |
| RhoGDI Signaling | 9.12E-09 | 129 | RANK Signaling in Osteoclasts | 1,82E-06 | 67 |
| p70S6K Signaling | 1.00E-08 | 95 | IL-17A Signaling in Airway Cells | 2,19E-06 | 51 |
| IL-8 Signaling | 1.02E-08 | 127 | Aminoacyl-tRNA Biosynthesis | 2,40E-06 | 30 |
| IL-15 Signaling | 1.15E-08 | 53 | G Beta Gamma Signaling | 2,51E-06 | 68 |
| fMLP Signaling in Neutrophils | 1.23E-08 | 85 | Telomerase Signaling | 2,69E-06 | 75 |
| Phospholipase C Signaling | 1.78E-08 | 163 | IL-6 Signaling | 3,16E-06 | 71 |
| PAK Signaling | 1.91E-08 | 72 | Role of BRCA1 in DNA Damage Response | 3,24E-06 | 46 |
| P2Y Purigenic Receptor Signaling Pathway | 2.24E-08 | 93 | Death Receptor Signaling | 3,39E-06 | 48 |
| HMGB1 Signaling | 3.02E-08 | 75 | IL-3 Signaling | 3,39E-06 | 56 |
| Leukocyte Extravasation Signaling | 3.16E-08 | 137 | Starch and Sucrose Metabolism | 3,47E-06 | 54 |
| RhoA Signaling | 3.89E-08 | 86 | GM-CSF Signaling | 3,47E-06 | 50 |
| PTEN Signaling | 4.07E-08 | 84 | Angiopoietin Signaling | 3,47E-06 | 52 |
| Virus Entry via Endocytic Pathways | 4.57E-08 | 72 | Non-Small Cell Lung Cancer Signaling | 3,47E-06 | 52 |
| Growth Hormone Signaling | 5.13E-08 | 57 | Role of NFAT in Regulation of the Immune | 3,72E-06 | 120 |
| JAK/Stat Signaling | 6.31E-08 | 52 | Response | | |
| Lymphotoxin β Receptor Signaling | 7.08E-08 | 47 | Neuregulin Signaling | 3,72E-06 | 67 |